TYK151
Verapamil should not be given for the treatment of SVT in patients with Wolff- Parkinson-White syndrome because:
a) It has not been shown to be effective at terminating SVT in these patients
b) It can precipitate ventricular tachydysrhythmias in these patients
c) Its onset of action is delayed in patients with WPW
d) Reflex tachycardia and decreased afterload may lead to hypertensive crisis
e) Verapamil is NOT contraindicated in patients with WPW
Click for Answer
Answer
Answer b.
Verapamil is effective at terminating SVT in older children and adults, but may precipitate ventricular tachydysrhythmias in patients with Wolf- Parkinson-White syndrome.
Notes
- This question originally printed in the Pediatric Anesthesiology Review Topics kindle book series, and appears courtesy of Naerthwyn Press, LLC.
Keywords